These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 2554104)

  • 41. Digitalis-like substance discovered in human plasma.
    Brady SR
    Hawaii Med J; 1989 Mar; 48(3):97. PubMed ID: 2543651
    [No Abstract]   [Full Text] [Related]  

  • 42. Comparison between endogenous digoxin-like immunoreactivity and 86Rb uptake by erythrocytes in extracts of human plasma.
    Balzan S; Montali U; Genovesi-Ebert A; Biver P; Fantoni M; Ghione S
    Clin Sci (Lond); 1989 Oct; 77(4):375-81. PubMed ID: 2553327
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A digoxin-like factor associates with erythrocyte sodium concentration, sodium transport, and ouabain binding.
    Hunt SC; Wu LL; Stults BM; Williams RR
    Clin Biochem; 1988 Jun; 21(3):183-6. PubMed ID: 3390908
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A ouabain-displacing factor in normal pregnancy, pregnancy-induced hypertension and pre-eclampsia.
    Gregoire I; Roth D; Siegenthaler G; Fievet P; el Esper N; Favre H; Fournier A
    Clin Sci (Lond); 1988 Mar; 74(3):307-10. PubMed ID: 2831007
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Partial purification and properties of a plasma ouabain-like inhibitor of Na+, K+-ATPase in patients with essential hypertension.
    Masugi F; Ogihara T; Sakaguchi K; Tomii A; Hasegawa T; Chen Y; Azuma M; Kumahara Y
    J Hypertens Suppl; 1988 Dec; 6(4):S351-3. PubMed ID: 2853743
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Involvement of ouabain (digitalis-like factor) in the pathogenesis of hypertension and hypertensive target-organ damage].
    Goto A; Yamada K
    Nihon Rinsho; 2004 Mar; 62 Suppl 3():169-73. PubMed ID: 15171364
    [No Abstract]   [Full Text] [Related]  

  • 47. [Disorders of cell membrane functions and primary arterial hypertension].
    Halawa B
    Pol Tyg Lek; 1992 Jul 6-13; 47(27-28):611-3. PubMed ID: 1336855
    [No Abstract]   [Full Text] [Related]  

  • 48. Role of ouabain-like factors and Na-K-ATPase inhibitors in hypertension--some old and recent findings.
    Haddy FJ; Pamnani MB
    Clin Exp Hypertens; 1998; 20(5-6):499-508. PubMed ID: 9682906
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Pathophysiology and laboratory examinations of essential hypertension--a review of recent topics].
    Takahashi H; Nishimura M; Yoshimura M
    Rinsho Byori; 1990 May; 38(5):563-7. PubMed ID: 2143238
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Platelet 5-HT content and uptake in essential hypertension: role of endogenous digitalis-like factors and plasma cholesterol.
    Guicheney P; Devynck MA; Cloix JF; Pernollet MG; Grichois ML; Meyer P
    J Hypertens; 1988 Nov; 6(11):873-9. PubMed ID: 2853193
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Plasma ouabain-like factor during acute and chronic changes in sodium balance in essential hypertension.
    Manunta P; Messaggio E; Ballabeni C; Sciarrone MT; Lanzani C; Ferrandi M; Hamlyn JM; Cusi D; Galletti F; Bianchi G;
    Hypertension; 2001 Aug; 38(2):198-203. PubMed ID: 11509476
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Increased circulating levels of an endogenous digoxin-like factor in hypertensive monkeys.
    Gruber KA; Rudel LL; Bullock BC
    Hypertension; 1982; 4(3):348-54. PubMed ID: 6279495
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Endogenous digoxin-like immunoreactive factor and digitalis-like factor associated with the hypertension of patients receiving multiple alkylating agents as part of autologous bone marrow transplantation.
    Graves SW; Eder JP; Schryber SM; Sharma K; Brena A; Antman KH; Peters WP
    Clin Sci (Lond); 1989 Nov; 77(5):501-7. PubMed ID: 2555106
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Simultaneous measurement of marinobufagenin, ouabain, and hypertension-associated protein in various disease states.
    Gonick HC; Ding Y; Vaziri ND; Bagrov AY; Fedorova OV
    Clin Exp Hypertens; 1998; 20(5-6):617-27. PubMed ID: 9682918
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Ouabain-like and non-ouabain-like factors in plasma of patients with essential hypertension.
    Masugi F; Ogihara T; Hasegawa T; Kumahara Y
    Clin Exp Hypertens A; 1987; 9(7):1233-42. PubMed ID: 3040306
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Endogenous natriuretic and ouabain-like factors. Their roles in body fluid volume and blood pressure regulation.
    Kramer HJ; Meyer-Lehnert H; Michel H; Predel HG
    Am J Hypertens; 1991 Jan; 4(1 Pt 1):81-9. PubMed ID: 1848764
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Ouabain-like factor.
    Goto A; Yamada K
    Curr Opin Nephrol Hypertens; 1998 Mar; 7(2):189-96. PubMed ID: 9529622
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Endogenous digitalis-like compounds in essential and experimental hypertension.
    Devynck MA; Pernollet MG; Meyer P
    Int J Rad Appl Instrum B; 1987; 14(4):341-52. PubMed ID: 3654254
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Erythrocyte Na,K pump activity and arterial hypertension in uremic dialyzed patients.
    Boero R; Guarena C; Berto IM; Deabate MC; Rosati C; Quarello F; Piccoli G
    Kidney Int; 1988 Nov; 34(5):691-6. PubMed ID: 2848975
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Role of the ouabain-like factor and Na-K pump in rat and human genetic hypertension.
    Ferrandi M; Manunta P; Rivera R; Bianchi G; Ferrari P
    Clin Exp Hypertens; 1998; 20(5-6):629-39. PubMed ID: 9682919
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.